174 related articles for article (PubMed ID: 16454557)
1. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder following lung transplantation is more commonly of host origin.
Peterson MR; Emery SC; Yung GL; Masliah E; Yi ES
Arch Pathol Lab Med; 2006 Feb; 130(2):176-80. PubMed ID: 16454557
[TBL] [Abstract][Full Text] [Related]
2. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.
Heyny-von Haussen R; Klingel K; Riegel W; Kandolf R; Mall G
Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335
[TBL] [Abstract][Full Text] [Related]
3. Posttransplantation lymphoproliferative disorders in pediatric patients undergoing liver transplantation.
Koh BY; Rosenthal P; Medeiros LJ; Osorio RW; Roberts JP; Ascher NL; Gelb AB
Arch Pathol Lab Med; 2001 Mar; 125(3):337-43. PubMed ID: 11231479
[TBL] [Abstract][Full Text] [Related]
4. Case Report: Non-negligible Epstein-Barr virus-associated posttransplant lymphoproliferative disorders in a lung transplant recipient.
Hu J; Yu YW; Han DS; Li XJ; Zhang YQ; Cai HL; Xiao YH; Zheng X
Front Immunol; 2023; 14():1244534. PubMed ID: 37781359
[TBL] [Abstract][Full Text] [Related]
5. Role of Epstein-Barr virus status and immunophenotypic studies in the evaluation of exfoliative cytology specimens from patients with post-transplant lymphoproliferative disorders.
Gibson SE; Picarsic J; Swerdlow SH; Pantanowitz L
Cancer Cytopathol; 2016 Jun; 124(6):425-35. PubMed ID: 26992116
[TBL] [Abstract][Full Text] [Related]
6. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
[TBL] [Abstract][Full Text] [Related]
7. The recipient origin of posttransplant lymphoproliferative disorders in pulmonary transplant patients. A report of three cases.
Wood BL; Sabath D; Broudy VC; Raghu G
Cancer; 1996 Nov; 78(10):2223-8. PubMed ID: 8918418
[TBL] [Abstract][Full Text] [Related]
8. Isolated pleural PTLD after cardiac transplantation.
Lamba M; Jabi M; Padmore R; Sengar DP; Veinot JP
Cardiovasc Pathol; 2002; 11(6):346-50. PubMed ID: 12459436
[TBL] [Abstract][Full Text] [Related]
9. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.
Gong JZ; Bayerl MG; Sandhaus LM; Sebastian S; Rehder CW; Routbort M; Lagoo AS; Szabolcs P; Chiu J; Comito M; Buckley PJ
Am J Surg Pathol; 2006 Mar; 30(3):328-36. PubMed ID: 16538052
[TBL] [Abstract][Full Text] [Related]
10. Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate.
Mentzer SJ; Perrine SP; Faller DV
Transpl Infect Dis; 2001 Sep; 3(3):177-85. PubMed ID: 11493400
[TBL] [Abstract][Full Text] [Related]
11. Donor or recipient origin of posttransplant lymphoproliferative disorders following solid organ transplantation.
Kinch A; Cavelier L; Bengtsson M; Baecklund E; Enblad G; Backlin C; Thunberg U; Sundström C; Pauksens K
Am J Transplant; 2014 Dec; 14(12):2838-45. PubMed ID: 25307322
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response.
Yang J; Tao Q; Flinn IW; Murray PG; Post LE; Ma H; Piantadosi S; Caligiuri MA; Ambinder RF
Blood; 2000 Dec; 96(13):4055-63. PubMed ID: 11110673
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation.
Montone KT; Litzky LA; Wurster A; Kaiser L; Bavaria J; Kotloff R; Palevsky H; Pietra GG; Tomaszewski JE
Surgery; 1996 May; 119(5):544-51. PubMed ID: 8619211
[TBL] [Abstract][Full Text] [Related]
14. Discrimination of Epstein-Barr virus-related posttransplant lymphoproliferations from acute rejection in lung allograft recipients.
Rosendale B; Yousem SA
Arch Pathol Lab Med; 1995 May; 119(5):418-23. PubMed ID: 7748068
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders.
Fellner MD; Durand KA; Solernou V; Bosaleh A; Balbarrey Z; García de Dávila MT; Rodríguez M; Irazu L; Alonio LV; Picconi MA
Rev Argent Microbiol; 2016; 48(2):110-8. PubMed ID: 27157146
[TBL] [Abstract][Full Text] [Related]
16. Posttransplant Lymphoproliferative Disorders in Epstein-Barr Virus Donor Positive/Recipient Negative Lung Transplant Recipients.
Courtwright AM; Burkett P; Divo M; Keller S; Rosas IO; Trindade A; Mody GN; Singh SK; El-Chemaly S; Camp PC; Goldberg HJ; Mallidi HR
Ann Thorac Surg; 2018 Feb; 105(2):441-447. PubMed ID: 29223419
[TBL] [Abstract][Full Text] [Related]
17. Acute cellular rejection and Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a pediatric lung transplant with low viral load.
Calabrese F; Loy M; Lunardi F; Marino D; Aversa SM; Rea F
Transpl Infect Dis; 2010 Aug; 12(4):342-6. PubMed ID: 20030794
[TBL] [Abstract][Full Text] [Related]
18. Characteristic pattern of chromosomal imbalances in posttransplantation lymphoproliferative disorders: correlation with histopathological subcategories and EBV status.
Poirel HA; Bernheim A; Schneider A; Meddeb M; Choquet S; Leblond V; Charlotte F; Davi F; Canioni D; Macintyre E; Mamzer-Bruneel MF; Hirsch I; Hermine O; Martin A; Cornillet-Lefebvre P; Patey M; Toupance O; Kémény JL; Deteix P; Raphaël M
Transplantation; 2005 Jul; 80(2):176-84. PubMed ID: 16041261
[TBL] [Abstract][Full Text] [Related]
19. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
[TBL] [Abstract][Full Text] [Related]
20. Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin.
Weissmann DJ; Ferry JA; Harris NL; Louis DN; Delmonico F; Spiro I
Am J Clin Pathol; 1995 Jun; 103(6):748-55. PubMed ID: 7785662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]